Frailty - UpToDate
Frailty
Frailty
Author:
Jeremy D Walston, MD
Section Editor:
Kenneth E Schmader, MD
Deputy Editor:
Jane Givens, MD, MSCE
Literature review current through: Mar 2024.
This topic last updated: Jun 12, 2023.

INTRODUCTION

Frailty is most often defined as an aging-related syndrome of physiological decline, characterized by marked vulnerability to adverse health outcomes. Frail older patients often present with an increased burden of symptoms including weakness and fatigue, medical complexity, and reduced tolerance to medical and surgical interventions. Awareness of frailty and associated risks for adverse health outcomes can improve care for this most vulnerable subset of patients.

Although there is no gold standard for detecting frailty, multiple frailty screening tools have been developed and utilized for risk assessment and epidemiologic study.

This topic will review the definitions, pathophysiology, prevalence, and diagnosis of frailty and clinical approaches that may attenuate vulnerability and relieve symptoms.

PREVALENCE

Many population-based studies of frailty have been performed using a variety of frailty measures. Although the prevalence of frailty varies with the tool used and with the population studied, prevalence in several studies in the United States ranges from 4 to 16 percent in community-dwelling men and women aged 65 and older [1-5] and up to 43 percent of older patients with cancer [6]. Pre-frailty (patients at risk for frailty who fulfill some, not but all, criteria for frailty) has a prevalence ranging from 28 to 44 percent in those over 65 years old [1,4,5].

A 2012 systematic review found that when frailty was defined on the basis of physical findings alone, overall prevalence in 15 studies (44,894 participants) was 9.9 percent; when psychosocial aspects were included in the definition, prevalence was 13.6 percent among eight studies (24,072 participants) [7]. In a European study (the Survey of Health, Ageing, and Retirement in Europe [SHARE]) comparing eight frailty scales, frailty prevalence ranged from 6 to 44 percent when applied to a database of individuals aged 50 to 104 years [8]. In a US study of people aged 90 and older, the prevalence of frailty was 24 percent for those aged 90 to 94 and 39.5 percent for those 95 and older [9].

Disclaimer: This generalized information is a limited summary of diagnosis, treatment, and/or medication information. It is not meant to be comprehensive and should be used as a tool to help the user understand and/or assess potential diagnostic and treatment options. It does NOT include all information about conditions, treatments, medications, side effects, or risks that may apply to a specific patient. It is not intended to be medical advice or a substitute for the medical advice, diagnosis, or treatment of a health care provider based on the health care provider's examination and assessment of a patient's specific and unique circumstances. Patients must speak with a health care provider for complete information about their health, medical questions, and treatment options, including any risks or benefits regarding use of medications. This information does not endorse any treatments or medications as safe, effective, or approved for treating a specific patient. UpToDate, Inc. and its affiliates disclaim any warranty or liability relating to this information or the use thereof. The use of this information is governed by the Terms of Use, available at https://www.wolterskluwer.com/en/know/clinical-effectiveness-terms. 2024© UpToDate, Inc. and its affiliates and/or licensors. All rights reserved.
Loading
Please wait